Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.345
-0.004 (-1.03%)
At close: Apr 28, 2026, 4:00 PM EDT
0.342
-0.003 (-0.84%)
After-hours: Apr 28, 2026, 6:21 PM EDT
Gossamer Bio Employees
As of December 31, 2025, Gossamer Bio had 162 total employees, including 161 full-time and 1 part-time employees. The number of employees increased by 17 or 11.72% compared to the previous year.
Employees
162
Change (1Y)
17
Growth (1Y)
11.72%
Revenue / Employee
$299,204
Profits / Employee
-$1,051,667
Market Cap
80.95M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Sangamo Therapeutics | 142 |
| Adicet Bio | 102 |
| PolyPid | 75 |
| eXoZymes | 32 |
| NeurAxis | 24 |
| Q32 Bio | 24 |
| Gain Therapeutics | 21 |
GOSS News
- 8 days ago - GOSS Stockholders Have Rights – If You Lost Money Investing in Gossamer Bio, Inc. Contact Robbins LLP for Information About Recovering Your Losses - GlobeNewsWire
- 8 days ago - Gossamer Bio, Inc. (GOSS) Securities Fraud: Contact Berger Montague To Discuss Your Rights - Newsfile Corp
- 15 days ago - Shareholders who lost money in Gossamer Bio, Inc (NASDAQ: GOSS) Should Contact Wolf Haldenstein Immediately - GlobeNewsWire
- 6 weeks ago - Gossamer Bio Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update - Business Wire
- 7 weeks ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1 - Benzinga
- 2 months ago - GOSS Investors Have Opportunity to Join Gossamer Bio, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
- 2 months ago - BREAKING: Gossamer Bio Investors Should Contact Block & Leviton to Potentially Recover Losses After Shares Fall Over 75% - GlobeNewsWire
- 2 months ago - Gossamer Bio Shareholders Are Encouraged to Contact Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire